ACEFLICK P Tablet – Aceclofenac 100mg + Paracetamol 325mg Smart Tablets

WHO-GMP Certified Manufacturing by Akums

PCD Pharma Franchise Opportunity for ACEFLICK P Tablet

Aceclofenac and Paracetamol Combination for Trade Distribution

Packaging, Pricing and Supply Details
Cafoli Lifecare – Trusted Partner for General Medicine Franchise

Home/Products /aceclofenac-100mg-paracetamol-325mg-tablet

Aceflick P Tablet

Composition : Aceclofenac (100mg) + Paracetamol (325mg) Tablet

Dosage Form : Smart Tablet

Packaging Type : Blister

Packaging : 20*10

Price : ₹103/-

Product Overview

ACEFLICK P Tablet is a branded pharmaceutical formulation from Cafoli Lifecare, developed for inclusion in general and pain management portfolios under Cafoli’s trade-focused product range.

This formulation is positioned for PCD pharma franchise distribution, wholesale supply, and institutional pharmaceutical trade, ensuring consistent quality, regulated documentation, and reliable supply for long-term business partnerships.

The product is formulated with a focus on:

  • Consistent batch-to-batch quality

  • Accurate and transparent composition labeling

  • Professional-grade blister packaging

  • Compliance with Indian pharmaceutical manufacturing and trade regulations

ACEFLICK P Tablet is suitable for distributors and franchise partners seeking stable, fast-moving products for their general medicine portfolios.

Manufacturing & Quality Standards

ACEFLICK P Tablet is manufactured by Akums, a well-established and trusted pharmaceutical manufacturer operating under WHO-GMP compliant facilities.

The product follows:

  • Standardized manufacturing protocols

  • Batch-wise quality control checks

  • Regulated documentation and traceability systems

  • Stability and packaging integrity standards

These practices ensure consistency, safety, and reliability, making the product suitable for pharmaceutical trade distribution across multiple regions.

Pricing Information (Trade)

  • MRP: ₹55 per strip

  • GST: As applicable

  • Pricing Structure: Trade-friendly and transparent

Target Trade Segment (B2B)

ACEFLICK P Tablet is supplied strictly through pharmaceutical trade channels and is intended for:

  • PCD Pharma Franchise Partners

  • Pharmaceutical Distributors & Stockists

  • Institutional & Bulk Medicine Supply

  • Hospital and Clinic Supply Chains

This product is not positioned for direct-to-consumer sale.

Availability & Supply

ACEFLICK P Tablet is available through Cafoli Lifecare’s structured distribution network, offering:

  • Reliable stock availability

  • Transparent dispatch timelines

  • Proper invoicing and GST-compliant documentation

  • Trade-supportive MOQ options for franchise partners

Why Include ACEFLICK P Tablet in Your Portfolio

  • Manufactured by a trusted WHO-GMP compliant manufacturer

  • Stable and consistent formulation quality

  • Professional blister packaging for trade distribution

  • Competitive pricing for distributor-level margins

  • Part of Cafoli Lifecare’s expanding general medicine portfolio

  • Suitable for long-term portfolio building by PCD and wholesale partners


Read More

About the Product

Product Overview

ACEFLICK P Tablet is a branded pharmaceutical formulation from Cafoli Lifecare, developed for inclusion in general and pain management portfolios under Cafoli’s trade-focused product range.

This formulation is positioned for PCD pharma franchise distribution, wholesale supply, and institutional pharmaceutical trade, ensuring consistent quality, regulated documentation, and reliable supply for long-term business partnerships.

The product is formulated with a focus on:

  • Consistent batch-to-batch quality

  • Accurate and transparent composition labeling

  • Professional-grade blister packaging

  • Compliance with Indian pharmaceutical manufacturing and trade regulations

ACEFLICK P Tablet is suitable for distributors and franchise partners seeking stable, fast-moving products for their general medicine portfolios.

Manufacturing & Quality Standards

ACEFLICK P Tablet is manufactured by Akums, a well-established and trusted pharmaceutical manufacturer operating under WHO-GMP compliant facilities.

The product follows:

  • Standardized manufacturing protocols

  • Batch-wise quality control checks

  • Regulated documentation and traceability systems

  • Stability and packaging integrity standards

These practices ensure consistency, safety, and reliability, making the product suitable for pharmaceutical trade distribution across multiple regions.

Pricing Information (Trade)

  • MRP: ₹55 per strip

  • GST: As applicable

  • Pricing Structure: Trade-friendly and transparent

Target Trade Segment (B2B)

ACEFLICK P Tablet is supplied strictly through pharmaceutical trade channels and is intended for:

  • PCD Pharma Franchise Partners

  • Pharmaceutical Distributors & Stockists

  • Institutional & Bulk Medicine Supply

  • Hospital and Clinic Supply Chains

This product is not positioned for direct-to-consumer sale.

Availability & Supply

ACEFLICK P Tablet is available through Cafoli Lifecare’s structured distribution network, offering:

  • Reliable stock availability

  • Transparent dispatch timelines

  • Proper invoicing and GST-compliant documentation

  • Trade-supportive MOQ options for franchise partners

Why Include ACEFLICK P Tablet in Your Portfolio

  • Manufactured by a trusted WHO-GMP compliant manufacturer

  • Stable and consistent formulation quality

  • Professional blister packaging for trade distribution

  • Competitive pricing for distributor-level margins

  • Part of Cafoli Lifecare’s expanding general medicine portfolio

  • Suitable for long-term portfolio building by PCD and wholesale partners


Common side effects may include nausea, stomach upset, dizziness, or rash. Prolonged use may cause gastrointestinal irritation or liver function changes. Consult your doctor if side effects persist or worsen.

Aceflick P Tablet is indicated for the management of pain and inflammation associated with musculoskeletal conditions, arthritis, and post-operative recovery.

Disclaimer: This product information is intended solely for pharmaceutical trade professionals, distributors, and PCD pharma franchise partners. ACEFLICK P Tablet is not promoted for direct consumer sale. All information is provided for business and regulatory reference purposes only and complies with applicable pharmaceutical regulations in India.

Store in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation